Business
Mayne Pharma reports $92 million loss – InDaily
Adelaide-based pharmaceutical company Mayne Pharma has reported a $92.8 million loss for the 2020 financial year, driven by asset write downs in its generic medicines business.
Advertisement
Advertisement
Today’s top stories
PS Canally helping Morgan steam ahead with tourist attraction
Adelaide Uni loses another senior leader
MPs refuse to release documents to ICAC’s entitlements probe
Your views: on COVID-19 marshalls, Centrelink, prison and planning
Rebuilding the Crows: the unthinkable becomes the strategy
Mayne Pharma reports $92 million loss
Adelaide-based pharmaceutical company Mayne Pharma has reported a $92.8 million loss for the 2020 financia…
-
Business15 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business11 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General21 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News11 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred